Cargando…

Metabolic Syndrome and Cognitive Functions in Schizophrenia—Implementation of Dietary Intervention

INTRODUCTION: The co-existence of schizophrenia and metabolic syndrome is a widely described phenomenon that contributes to the worse functioning of patients in everyday life. A relatively new area of research is the relationship between metabolic syndrome (MS) and cognitive function in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamowicz, Katarzyna, Mazur, Aleksandra, Mak, Monika, Samochowiec, Jerzy, Kucharska-Mazur, Jolanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203414/ https://www.ncbi.nlm.nih.gov/pubmed/32425834 http://dx.doi.org/10.3389/fpsyt.2020.00359

Ejemplares similares

Dietary Behaviors and Metabolic Syndrome in Schizophrenia Patients
por: Adamowicz, Katarzyna, et al.
Publicado: (2020)

Sterile Inflammation of Brain, due to Activation of Innate Immunity, as a Culprit in Psychiatric Disorders
por: Ratajczak, Mariusz Z., et al.
Publicado: (2018)

Cognitive Dysfunctions Measured with the MCCB in Deficit and Non-Deficit Schizophrenia
por: Plichta, Piotr, et al.
Publicado: (2023)

Color Trails Test: A New Set of Data on Cognitive Flexibility and Processing Speed in Schizophrenia
por: Tyburski, Ernest, et al.
Publicado: (2020)

Physiotherapy and Physical Activity as Factors Improving the Psychological State of Patients With Cancer
por: Zyzniewska-Banaszak, Ewelina, et al.
Publicado: (2021)

Association between DRD2 and ANKK1 polymorphisms with the deficit syndrome in schizophrenia
por: Michalczyk, Anna, et al.
Publicado: (2020)

Neurocognition and Social Cognition— Possibilities for Diagnosis and Treatment in Ultra-High Risk for Psychosis State
por: Rek-Owodziń, Katarzyna, et al.
Publicado: (2021)

The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia
por: Rek-Owodziń, Katarzyna, et al.
Publicado: (2022)

Psychopathology and Integrity of the Superior Longitudinal Fasciculus in Deficit and Nondeficit Schizophrenia
por: Podwalski, Piotr, et al.
Publicado: (2022)

Assessment of Complement Cascade Components in Patients With Bipolar Disorder
por: Reginia, Artur, et al.
Publicado: (2018)

Executive Functions and Psychopathology Dimensions in Deficit and Non-Deficit Schizophrenia
por: Bielecki, Maksymilian, et al.
Publicado: (2023)

The relationship between white matter integrity of superior longitudinal fascicle and cognitive functions in chronic schizophrenia
por: Tyburski, E., et al.
Publicado: (2022)

Personality-Related Factors and Depressive Symptomatology Predict Behavioral Control in Patients With Alcohol Use Disorders
por: Lebiecka, Zofia, et al.
Publicado: (2022)

Serum Inflammatory Markers and Their Associations with the Integrity of the Cingulum Bundle in Schizophrenia, from Prodromal Stages to Chronic Psychosis
por: Michalczyk, Anna, et al.
Publicado: (2022)

Relationship between White Matter Alterations and Pathophysiological Symptoms in Patients with Ultra-High Risk of Psychosis, First-Episode, and Chronic Schizophrenia
por: Waszczuk, Katarzyna, et al.
Publicado: (2022)

Serum Inflammatory Markers and Integrity of the Superior Longitudinal Fasciculus and the Inferior Longitudinal Fasciculus in Schizophrenia, from Prodromal Stages to Chronic Psychosis—A Cross-Sectional Study
por: Michalczyk, Anna, et al.
Publicado: (2023)

Is Virtual Reality Cue Exposure a Promising Adjunctive Treatment for Alcohol Use Disorder?
por: Lebiecka, Zofia, et al.
Publicado: (2021)

Complement Activation Products in Patients with Chronic Schizophrenia
por: Rudkowski, Krzysztof, et al.
Publicado: (2023)

Adverse Childhood Experiences and Neurocognition in Schizophrenia Spectrum Disorders: Age at First Exposure and Multiplicity Matter
por: Kasznia, Justyna, et al.
Publicado: (2021)

White Matter Integrity of the Corpus Callosum and Psychopathological Dimensions in Deficit and Non-Deficit Schizophrenia Patients
por: Podwalski, Piotr, et al.
Publicado: (2021)

Do Personality, Alcohol Abstinence Self-Efficacy, and Depressive Symptomatology Affect Abstinence Status in Treatment-Seeking Patients with Alcohol Use Disorder?
por: Lebiecka, Zofia, et al.
Publicado: (2022)

Analysis of Gut Microbiota and Their Metabolic Potential in Patients with Schizophrenia Treated with Olanzapine: Results from a Six-Week Observational Prospective Cohort Study
por: Pełka-Wysiecka, Justyna, et al.
Publicado: (2019)

Assessment of the Association Between Cigarette Smoking and Cognitive Performance in Patients With Schizophrenia-Spectrum Disorders: A Case-Control Study
por: Stramecki, Filip, et al.
Publicado: (2018)

Relationship of Corpus Callosum Integrity with Working Memory, Planning, and Speed of Processing in Patients with First-Episode and Chronic Schizophrenia
por: Tyburski, Ernest, et al.
Publicado: (2021)

Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia
por: Koricanac, Aleksandra, et al.
Publicado: (2022)

Improving Cognition to Increase Treatment Efficacy in Schizophrenia: Effects of Metabolic Syndrome on Cognitive Remediation's Outcome
por: Bosia, Marta, et al.
Publicado: (2018)

Neuropsychological Profile of Specific Executive Dysfunctions in Patients with Deficit and Non-deficit Schizophrenia
por: Tyburski, Ernest, et al.
Publicado: (2017)

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
por: MacKenzie, Nicole E., et al.
Publicado: (2018)

Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What’s the Evidence?
por: Vingerhoets, Wilhelmina A. M., et al.
Publicado: (2013)

Association between lipid metabolism and cognitive function in patients with schizophrenia
por: Liu, Huamin, et al.
Publicado: (2022)

Editorial: Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?
por: Misiak, Błazej, et al.
Publicado: (2019)

Metaphor Processing Dysfunctions in Schizophrenia Patients With and Without Substance Use Disorders
por: Karabanowicz, Ewa, et al.
Publicado: (2020)

Assessment and Treatment of Negative Symptoms in Schizophrenia—A Regional Perspective
por: Bitter, Istvan, et al.
Publicado: (2022)

ATP-Nlrp3 Inflammasome-Complement Cascade Axis in Sterile Brain Inflammation in Psychiatric Patients and its Impact on Stem Cell Trafficking
por: Ratajczak, Mariusz Z., et al.
Publicado: (2019)

Psychopathology and Stem Cell Mobilization in Ultra-High Risk of Psychosis and First-Episode Psychosis Patients
por: Waszczuk, Katarzyna, et al.
Publicado: (2022)

Effects of the interaction between PTSD and ADHD symptoms on the level of reporting psychotic-like experiences: findings from a non-clinical population
por: Gelner, Hanna, et al.
Publicado: (2023)

Effects of Cognitive Remediation on Cognition, Metacognition, and Social Cognition in Patients With Schizophrenia
por: Montemagni, Cristiana, et al.
Publicado: (2021)

Cognitive Remediation for Schizophrenia with Focus on NEAR
por: Mogami, Tamiko
Publicado: (2018)

White Matter Measures and Cognition in Schizophrenia
por: Erkol, Cemre, et al.
Publicado: (2020)

Markers of Regenerative Processes in Patients with Bipolar Disorder: A Case-control Study
por: Reginia, Artur, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pi07f24au1q3mpm7hr70ofpca3